Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Thermal applicators
Reexamination Certificate
2000-12-08
2002-12-17
Gibson, Roy D. (Department: 3739)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Thermal applicators
C607S102000, C607S105000
Reexamination Certificate
active
06496737
ABSTRACT:
INCORPORATION BY REFERENCE
The aforementioned U.S. application Ser. No. 09/303,259 is hereby incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
The present invention relates to a thermal treatment catheter, and more particularly to a catheter having a thin outer wall and a defined fluid flow path within the outer wall to improve the effects of conductive cooling of the wall of the body conduit in which the catheter is inserted.
The prostate gland is a complex, chestnut-shaped organ which encircles the urethra immediately below the bladder. Nearly one third of the prostate tissue anterior to the urethra consists of fibromuscular tissue that is anatomically and functionally related to the urethra and the bladder. The remaining two thirds of the prostate is generally posterior to the urethra and is comprised of glandular tissue. The portion of the urethra extending through the prostate (i.e., the prostatic urethra) includes a proximal segment, which communicates with the bladder, and a distal segment, which extends at an angle relative to the proximal segment by the verumontanum.
Although a relatively small organ, the prostate is the most frequently diseased of all internal organs and is often the site of a common affliction among older men, benign prostatic hyperplasia (BPH), as well as a more serious affliction, cancer. BPH is a nonmalignant, bilateral expansion of prostate tissue occurring mainly in the transition zone of the prostate adjacent to the proximal segment of the prostatic urethra. As this tissue grows in volume, it encroaches on the urethra extending into the region of the bladder neck at the base of the bladder. Left untreated, BPH causes obstruction of the urethra which usually results in increased urinary frequency, urgency, incontinence, nocturia and slow or interrupted urinary stream. BPH may also result in more severe complications, such as urinary tract infection, acute urinary retention, hydronephrosis and uraemia.
Benign prostatic hyperplasia (BPH) may be treated using transurethral thermal therapy as described in further detail in U.S. Pat. No. 5,413,588 entitled DEVICE AND METHOD POR ASYMMETRICAL THERMAL THERAPY WITH HELICAL DIPOLE MICROWAVE ANTENNA and in U.S. Pat. No. 5,575,811 entitled BENIGN PROSTATIC HYPERPLASIA TREATMENT CATHETER WITH URETHRAL COOLING, both of which are hereby incorporated by reference. During transurethral thermal therapy, the transition zone of the prostate is heated to necrose the tumorous tissue that encroaches on the urethra. Transurethral thermal therapy is administered by use of a microwave antenna-containing catheter which includes a multi-lumen shaft. The catheter is positioned in the urethra with the microwave antenna located adjacent to the hyperplastic prostatic tissue. Energization of the microwave antenna causes the antenna to emit electromagnetic energy which heats tissue within the prostate. A cooling fluid is circulated through the catheter to preserve tissue such as the urethral wall between the microwave antenna and the target tissue of the prostate.
The commercially available Targis™ system from Urologix, Inc. of Minneapolis, MN employs a thermal therapy catheter that embodies the aforementioned U.S. Pat. No. 5,413,588, and is a product capable of performing thermal therapy of the prostate with microwave energy delivered from an applicator positioned in the urethra. The TargiST system has achieved substantial clinical and commercial success, indicating the efficacy of microwave thermal therapy for treating prostate disease. This therapy is benefitted by further developments in the technology of thermal therapy catheters to enhance the effects of microwave treatment of the prostate.
BRIEF SUMMARY OF THE INVENTION
The present invention is a device and method for treating tissue adjacent to a body lumen such as a urethra. A catheter shaft having an outer surface is insertable into the body lumen, and the catheter shaft carries an energy-emitting element. A multi-lobe balloon is positioned around the outer surface of the catheter shaft adjacent to the energy-emitting element, with opposing ends of the multi-lobe balloon being sealingly connected to the catheter shaft to form a chamber between the multi-lobe balloon and the outer surface of the catheter shaft. Fluid is circulated between the outer surface of the catheter shaft and the multi-lobe balloon in a defined fluid flow path to firmly contact the wall of the body lumen and thereby cool the body lumen tissue while thermally treating targeted tissue at a depth from the body lumen wall.
REFERENCES:
patent: 4342316 (1982-08-01), Rosenberg
patent: 4406656 (1983-09-01), Hattler et al.
patent: 4643186 (1987-02-01), Rosen et al.
patent: 4662383 (1987-05-01), Sogawa et al.
patent: 4676258 (1987-06-01), Inokuchi et al.
patent: 4825880 (1989-05-01), Stauffer et al.
patent: 4878495 (1989-11-01), Grayzel
patent: 4887614 (1989-12-01), Shirakami et al.
patent: 4983165 (1991-01-01), Loiterman
patent: 5007437 (1991-04-01), Sterzer
patent: 5015231 (1991-05-01), Keith et al.
patent: 5108370 (1992-04-01), Walinsky
patent: 5195965 (1993-03-01), Shantha
patent: 5226887 (1993-07-01), Farr et al.
patent: 5304214 (1994-04-01), DeFord et al.
patent: 5308323 (1994-05-01), Sogawa et al.
patent: 5308356 (1994-05-01), Blackshear, Jr. et al.
patent: 5350361 (1994-09-01), Tsukashima et al.
patent: 5383856 (1995-01-01), Bersin
patent: 5496271 (1996-03-01), Burton et al.
patent: 5501667 (1996-03-01), Verduin, Jr.
patent: 5505702 (1996-04-01), Arney
patent: 5549559 (1996-08-01), Eshel
patent: 5645529 (1997-07-01), Fagan et al.
patent: 5800486 (1998-09-01), Thome et al.
patent: 5843144 (1998-12-01), Rudie et al.
patent: 5861021 (1999-01-01), Thome et al.
patent: 5899932 (1999-05-01), Dann et al.
patent: 5916240 (1999-06-01), Rudie et al.
patent: 5931860 (1999-08-01), Reid et al.
patent: 5938692 (1999-08-01), Rudie
patent: 5987360 (1999-11-01), McGrath et al.
patent: 5992419 (1999-11-01), Sterzer et al.
patent: 6002968 (1999-12-01), Edwards
patent: 6007571 (1999-12-01), Neilson et al.
patent: 6009351 (1999-12-01), Flachman
patent: 6096030 (2000-08-01), Ortiz
patent: 6122551 (2000-09-01), Rudie et al.
patent: 4-28377 (1992-01-01), None
Crabb Joel
Ebner Bruce W.
Flachman Jonathan L.
Hjelle Aaron
Kluge Stan
Gibson Roy D.
Kinney & Lange , P.A.
Urologix Inc.
LandOfFree
Thermal therapy catheter does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thermal therapy catheter, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thermal therapy catheter will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2986635